Osteoporosis Clinical Trials 2024

Osteoporosis Clinical Trials 2024

Osteoporosis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in osteoporosis clinical trials today.

Osteoporosis Clinical Trials

Here are the 6 most popular medical studies for osteoporosis

Popular filter options for osteoporosis trials

Phase 3 Osteoporosis Clinical Trials

View 61 phase 3 osteoporosis medical studies.

Osteoporosis Clinical Trials With No Placebo

View 61 osteoporosis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to osteoporosis

What are the top hospitals conducting osteoporosis research?

When it comes to advancing the treatment and understanding of osteoporosis, top hospitals across the United States are making significant contributions through their clinical trials. In West Orange, New jersey, the Kessler Institute for Rehabilitation is at the forefront with three active trials focused on this bone-weakening condition. Since conducting their first trial in 2006, they have been dedicated to finding innovative approaches to managing osteoporosis. Similarly, in the Bronx, New york, the James J. Peters VA Medical Center is actively involved in three ongoing trials and has recorded four all-time studies since initiating their first trial in 2015.

Moving westward to Aurora, Colorado's University of Colorado Anschutz Medical Campus joins this lineup with two active osteoporosis trials aiming to improve our understanding of this disease and develop novel treatments. Having commenced their first trial as recently as 2016 proves that they are committed to tackling one of today's pressing health concerns.

Meanwhile, UPMC Senior Communities located in Pittsburgh contributes significantly by conducting two ongoing clinical investigations into osteoporosis while having accomplished two prior trials since recording its pioneering investigation on such cases just five years ago back then from its very own establishment year itself i.e., also being conducted in 2016

Lastly but not leastly! The University of California Los Angeles (UCLA) rounds out this esteemed group with two currently running trials and a history of two completed studies dating back until thier earliest recorded involvement way back around2002 which adds substantial value towards expanding our knowledge base about how we can better manage or prevent Osteoporotic conditions.

These hospitals demonstrate an unwavering commitment not only towards improving patients' lives but also pushing boundaries within medical research communities; these tireless efforts will undoubtedly pave new paths toward improved prevention strategies and effective management techniques for individuals living with osteoporosis.

Which are the best cities for osteoporosis clinical trials?

When it comes to osteoporosis clinical trials, several cities have emerged as leaders in research and development. New york, with its 8 active trials, explores treatments such as Zoledronic acid (ZA), Romosozumab, and Vital signs. Aurora, Colorado follows closely behind with 7 ongoing studies focused on interventions like Exercise, Zoledronic acid (ZA), and Calcium Infusion. Additionally, Chicago in Illinois boasts 7 active trials examining treatments such as Zoledronic acid (ZA), Romosozumab, and Surgical Intervention. Lastly, Boston in Massachusetts offers 7 active trials investigating options like Zoledronic acid (ZA), Reference Point Indentation, and Romosozumab/denosumab combination therapy. Pittsburgh in Pennsylvania also contributes to the advancement of osteoporosis care with its 5 ongoing trials centered around treatments like Romosozumab and Zoledronic Acid. These cities serve as hubs for cutting-edge clinical research that aims to improve outcomes for individuals affected by osteoporosis.

Which are the top treatments for osteoporosis being explored in clinical trials?

Osteoporosis research is advancing rapidly, with several promising treatments taking center stage in clinical trials. Leading the pack is romosozumab, currently being explored in four active trials for osteoporosis. Since its introduction in 2009, it has been involved in a total of 16 clinical trials dedicated to this condition. Another notable contender is denosumab, which has two ongoing trials and an impressive history of 47 all-time osteoporosis studies since its first listing in 2003. Finally, we have donepezil making waves as well with one active trial and marking its debut on the scene in 2023 specifically for osteoporosis exploration. These developments offer hope for improved treatment options to combat this common bone disorder.

What are the most recent clinical trials for osteoporosis?

Exciting advancements in the field of osteoporosis treatment are underway, as recent clinical trials offer new possibilities for patients. One notable trial explores the potential benefits of donepezil, a medication traditionally used to treat Alzheimer's disease, in tackling osteoporosis. Another study focuses on romosozumab, which has shown promise as a therapy for this condition during its Phase 1 investigation. Additionally, zoledronic acid is being examined in a Phase 4 trial to assess its effectiveness and safety profile further. These significant research endeavors aim to enhance our understanding and management of osteoporosis while providing hope for improved outcomes moving forward.

What osteoporosis clinical trials were recently completed?

In the realm of osteoporosis research, several recent clinical trials have made strides in advancing our understanding and treatment options. Teva Pharmaceuticals USA completed a trial for TVB-009 in March 2021, while Roswell Park Cancer Institute wrapped up their investigation into Denosumab in December 2019. Additionally, Sandoz concluded its GP2411 study in July 2019. These trials demonstrate ongoing efforts to combat osteoporosis and provide hope for improved therapies that can alleviate the burden this condition places on individuals' bone health.